Copy responder link
Copy
Published
Section 1 of 1
Real World Outcome of Eculizumab in Post-Kidney Transplant TMA 
Kindly fill out a separate Google Form/link for each patient
Kindly fill out a separate Google Form/link for each patient
Loading...
Loading…
A. Center and respondent details
A. Center and respondent details
Loading...
Loading…
1. Name of transplant center 
1. Name of transplant center 
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…

2. City/state/country

2. City/state/country

Loading...
Loading…
City
City
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
State
State
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
Country
Country
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
3. Type of Center
3. Type of Center
Question Type
Loading image…
Government
Private
Trust
Academic
Other:
Add option
…
Answer key
(0 points)
Loading...
Loading…
4. Annual Kidney Transplant Volume
4. Annual Kidney Transplant Volume
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
5. Respondent Name/Designation
5. Respondent Name/Designation
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
6. Contact - Email ID
6. Contact - Email ID
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
7.  Contact - Mobile Number
7.  Contact - Mobile Number
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
8. Does your center maintain a transplant TMA registry?
8. Does your center maintain a transplant TMA registry?
Question Type
Loading image…
Yes
No
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…

B. Incidence and Prevalence

B. Incidence and Prevalence

Loading...
Loading…
1. Total kidney transplants performed in last 5 years:
1. Total kidney transplants performed in last 5 years:
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…

2. Number of suspected post-transplant TMA cases:

2. Number of suspected post-transplant TMA cases:

Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
3. Number of biopsy-proven TMA cases:
3. Number of biopsy-proven TMA cases:
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…

4. Number of systemic TMA cases:

4. Number of systemic TMA cases:

Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…

5. Number of kidney-limited TMA cases:

5. Number of kidney-limited TMA cases:

Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…

6. Timing of TMA after transplant:

6. Timing of TMA after transplant:

Question Type
Loading image…
7 days
7–30 days
1–3 months
3–6 months
> 6 months
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…

7. Classification:

7. Classification:

Question Type
Loading image…
Recurrent aHUS/TMA
De novo post-transplant TMA
Uncertain
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…

C. Recipient and Transplant Details

C. Recipient and Transplant Details

Loading...
Loading…
1. Recipient Age
1. Recipient Age
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
2. Recipient Gender
2. Recipient Gender
Question Type
Loading image…
Male
Female
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
3. Native Kidney Disease
3. Native Kidney Disease
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
4. History of TMA/aHUS before Transplant
4. History of TMA/aHUS before Transplant
Question Type
Loading image…
Yes
No
Unknown
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
5. Previous Graft Loss due to TMA
5. Previous Graft Loss due to TMA
Question Type
Loading image…
Yes
No
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
6. Donor Type
6. Donor Type
Question Type
Loading image…
Living Related
Living Unrelated
Deceased
ABO-incompatible
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
7. HLA Mismatch
7. HLA Mismatch
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
8. DSA present Pre-Transplant
8. DSA present Pre-Transplant
Question Type
Loading image…
Yes
No
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
9. Induction Used
9. Induction Used
Question Type
Loading image…
Basiliximab
ATG
Alemtuzumab
None
Other
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
10. Maintenance Immunosuppression
10. Maintenance Immunosuppression
Question Type
Loading image…
Tacrolimus
Cyclosporine
mTOR inhibitor
MMF/MPA
Steroids
Belatacept
Other
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
11. CNI/mTOR trough level at TMA diagnosis
11. CNI/mTOR trough level at TMA diagnosis
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
D. Clinical presentation
D. Clinical presentation
Loading...
Loading…
1. Presentation
1. Presentation
Question Type
Loading image…
Graft dysfunction
Oliguria
Hypertension/Worsening BP
Proteinuria
Anemia
Thrombocytopenia
GI Symptoms
Cardiovascular Symptoms
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
2. Serum Creatinine at Diagnosis
2. Serum Creatinine at Diagnosis
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
3. Urine protein/Creatinine ratio
3. Urine protein/Creatinine ratio
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
4. BP at Diagnosis
4. BP at Diagnosis
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
5. Need for Dialysis
5. Need for Dialysis
Question Type
Loading image…
Yes
No
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
E. Laboratory Diagnosis
E. Laboratory Diagnosis
Loading...
Loading…
1. Hemoglobin
1. Hemoglobin
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
2. Platelet Count
2. Platelet Count
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
3. LDH
3. LDH
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
4. Haptoglobin
4. Haptoglobin
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
5. Reticulocyte Count
5. Reticulocyte Count
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
6.  Schistocytes on Peripheral Smear
6.  Schistocytes on Peripheral Smear
Question Type
Loading image…
Yes
No
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
7. Direct Coombs test
7. Direct Coombs test
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
8.  C3
8.  C3
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
9. C4
9. C4
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
10. ADAMTS13 activity tested
10. ADAMTS13 activity tested
Question Type
Loading image…
Yes
No
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
IF YES: 
RESULT
IF YES: 
RESULT
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
11. STEC/Shiga toxin testing done
11. STEC/Shiga toxin testing done
Question Type
Loading image…
Yes
No
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
IF YES: 
RESULT
IF YES: 
RESULT
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
12. Other Infection Identified
12. Other Infection Identified
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
13. Anti-factor H Antibody Tested
13. Anti-factor H Antibody Tested
Question Type
Loading image…
Yes
No
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
IF YES: 
RESULT
IF YES: 
RESULT
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
14. Complement Genetic Testing Done
14. Complement Genetic Testing Done
Question Type
Loading image…
Yes
No
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
IF YES: 
IF YES: 
Question Type
Loading image…
CFH
CFI
C3
CFB
CD46
CFHR
DGKE
THBD
ADAMTS13
Other:
Add option
…
Answer key
(0 points)
Loading...
Loading…
15. Variant classification
15. Variant classification
Question Type
Loading image…
Pathogenic
Likely pathogenic
VUS
Negative
Not Available
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
F. Biopsy and Rejection Assessment
F. Biopsy and Rejection Assessment
Loading...
Loading…
1. Graft Biopsy Performed
1. Graft Biopsy Performed
Question Type
Loading image…
Yes
No
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
2. Biopsy timing from TMA Suspicion
2. Biopsy timing from TMA Suspicion
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
3. Biopsy findings:
3. Biopsy findings:
Question Type
Loading image…
Glomerular Thrombi
Arteriolar Thrombi
Endothelial Swelling
Mesangiolysis
Fibrinoid Necrosis
Cortical Necrosis
Chronic TMA Lesions
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
4. C4d staining
4. C4d staining
Question Type
Loading image…
Positive
Negative
Not done
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
5. Microvascular Inflammation
5. Microvascular Inflammation
Question Type
Loading image…
Yes
No
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
6. DSA at Diagnosis
6. DSA at Diagnosis
Question Type
Loading image…
Positive
Negative
Not done
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
7. ABMR Diagnosed
7. ABMR Diagnosed
Question Type
Loading image…
Yes
No
Possible
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
8. TCMR present
8. TCMR present
Question Type
Loading image…
Yes
No
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
9. Electron Microscopy Done
9. Electron Microscopy Done
Question Type
Loading image…
Yes
No
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
10. Final biopsy impression
10. Final biopsy impression
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
G. Suspected trigger
G. Suspected trigger
Loading...
Loading…
1. Most likely trigger
1. Most likely trigger
Question Type
Loading image…
Recurrent aHUS
ABMR
High CNI level
mTOR inhibitor
CMV
BK virus
Other infection
Ischemia-reperfusion Injury
ABO-Incompatible Transplant
Malignant Hypertension
Autoimmune Disease
Drug-Induced
Unknown/multifactorial
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
2. Was more than one trigger present? 
2. Was more than one trigger present? 
Question Type
Loading image…
Yes
No
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
H. Treatment details
H. Treatment details
Loading...
Loading…
1. Initial Management
1. Initial Management
Question Type
Loading image…
CNI Dose Reduction
CNI Withdrawal
mTOR Withdrawal
Switch to Belatacept
Plasma Exchange
IVIG
Steroids
Rituximab
ABMR Therapy
Antiviral/antibiotic therapy
Supportive care only
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
2.  Was Eculizumab Used? 
2.  Was Eculizumab Used? 
Question Type
Loading image…
Yes
No
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
3. Indication for Eculizumab
3. Indication for Eculizumab
Question Type
Loading image…
Prophylaxis for recurrent aHUS
Treatment of recurrent TMA
Treatment of de novo TMA
Rescue After Failure of Conventional Treatment
Severe Systemic TMA
Kidney-limited biopsy-proven TMA
ABMR not Responding to Conventional Treatment
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
4. Time from Diagnosis to First Eculizumab Dose
4. Time from Diagnosis to First Eculizumab Dose
Question Type
Loading image…
<24 hours
1–3 days
4–7 days
> 7 days
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
5. Eculizumab Dosing Schedule Used
5. Eculizumab Dosing Schedule Used
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
6. Number of Doses
6. Number of Doses
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
7. Duration of Therapy
7. Duration of Therapy
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
8. Was Ravulizumab Used Later? 
8. Was Ravulizumab Used Later? 
Question Type
Loading image…
Yes
No
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
9. Reason for stopping eculizumab
9. Reason for stopping eculizumab
Question Type
Loading image…
Completed protocol
Cost
Infection
No Response
Graft Loss
Ongoing Therapy
Achieved remission
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
10. Vaccination before Eculizumab
10. Vaccination before Eculizumab
Question Type
Loading image…
Meningococcal
Pneumococcal
H. Influenzae
Not done
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
11. Antibiotic prophylaxis given? 
11. Antibiotic prophylaxis given? 
Question Type
Loading image…
Yes
No
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
12. Funding source
12. Funding source
Question Type
Loading image…
Self-pay
Insurance
Government Scheme
Hospital Support
Company Access Program
Other:
Add option
…
Answer key
(0 points)
Loading...
Loading…
I. Outcomes
I. Outcomes
Loading...
Loading…
1. Hematological Response
1. Hematological Response
Question Type
Loading image…
Complete
Partial
None
Not applicable
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
2. Platelet Recovery Day
2. Platelet Recovery Day
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
3.  LDH Normalization Day
3.  LDH Normalization Day
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
4.  Creatinine at 1 Month
4.  Creatinine at 1 Month
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
5.  Creatinine at 3 Months
5.  Creatinine at 3 Months
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
6.  Creatinine at 6 Months
6.  Creatinine at 6 Months
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
7.  Creatinine at 12 Months
7.  Creatinine at 12 Months
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
8.  Dialysis Discontinued? 
8.  Dialysis Discontinued? 
Question Type
Loading image…
Yes
No
Not applicable
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
9.  Graft Outcome
9.  Graft Outcome
Question Type
Loading image…
Functioning Graft
Partial Recovery
Graft loss
Patient Death
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
10.  TMA Recurrence after Treatment Withdrawal
10.  TMA Recurrence after Treatment Withdrawal
Question Type
Loading image…
Yes
No
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
11.  Infection after Eculizumab
11.  Infection after Eculizumab
Question Type
Loading image…
Yes
No
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
If Yes
Kindly name the infection
If Yes
Kindly name the infection
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
12.  Other Adverse Events
12.  Other Adverse Events
Question Type
Loading image…
Answer key
(0 points)
Loading...
Loading…
13.  Mortality
13.  Mortality
Question Type
Loading image…
Yes
No
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
J. Real-world Barriers and Opinion
J. Real-world Barriers and Opinion
Loading...
Loading…
1.  Main Barriers to Eculizumab Use
1.  Main Barriers to Eculizumab Use
Question Type
Loading image…
Cost
Availability
Diagnostic Uncertainty
Delay in Approval
Vaccination Concerns
Infection Risk
Lack of Protocol
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…

2. In which Cases would you Consider Eculizumab?

2. In which Cases would you Consider Eculizumab?

Question Type
Loading image…
Recurrent aHUS only
Severe de novo TMA
Biopsy-proven kidney-limited TMA
TMA refractory to CNI withdrawal/ABMR treatment
All complement-mediated cases
ABMR not responding to conventional Treatment
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
3. Do you support Creating a National Post-Transplant TMA Registry? 
3. Do you support Creating a National Post-Transplant TMA Registry? 
Question Type
Loading image…
Yes
No
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
4.  Are you Willing to Contribute Anonymized Cases? 
4.  Are you Willing to Contribute Anonymized Cases? 
Question Type
Loading image…
Yes
No
Add option
or
add "Other"
…
Answer key
(0 points)
Loading...
Loading…
Link to Sheets
Insights
Total points distribution
Loading...
Loading responses…
Kindly fill out a separate Google Form/link for each patient
A. Center and respondent details
1. Name of transplant center 
Copy chart
No responses yet for this question.

2. City/state/country

City
Copy chart
No responses yet for this question.
State
Copy chart
No responses yet for this question.
Country
Copy chart
No responses yet for this question.
3. Type of Center
Copy chart
No responses yet for this question.
4. Annual Kidney Transplant Volume
Copy chart
No responses yet for this question.
5. Respondent Name/Designation
Copy chart
No responses yet for this question.
6. Contact - Email ID
Copy chart
No responses yet for this question.
7.  Contact - Mobile Number
Copy chart
No responses yet for this question.
8. Does your center maintain a transplant TMA registry?
Copy chart
No responses yet for this question.

B. Incidence and Prevalence

1. Total kidney transplants performed in last 5 years:
Copy chart
No responses yet for this question.

2. Number of suspected post-transplant TMA cases:

Copy chart
No responses yet for this question.
3. Number of biopsy-proven TMA cases:
Copy chart
No responses yet for this question.

4. Number of systemic TMA cases:

Copy chart
No responses yet for this question.

5. Number of kidney-limited TMA cases:

Copy chart
No responses yet for this question.

6. Timing of TMA after transplant:

Copy chart
No responses yet for this question.

7. Classification:

Copy chart
No responses yet for this question.

C. Recipient and Transplant Details

1. Recipient Age
Copy chart
No responses yet for this question.
2. Recipient Gender
Copy chart
No responses yet for this question.
3. Native Kidney Disease
Copy chart
No responses yet for this question.
4. History of TMA/aHUS before Transplant
Copy chart
No responses yet for this question.
5. Previous Graft Loss due to TMA
Copy chart
No responses yet for this question.
6. Donor Type
Copy chart
No responses yet for this question.
7. HLA Mismatch
Copy chart
No responses yet for this question.
8. DSA present Pre-Transplant
Copy chart
No responses yet for this question.
9. Induction Used
Copy chart
No responses yet for this question.
10. Maintenance Immunosuppression
Copy chart
No responses yet for this question.
11. CNI/mTOR trough level at TMA diagnosis
Copy chart
No responses yet for this question.
D. Clinical presentation
1. Presentation
Copy chart
No responses yet for this question.
2. Serum Creatinine at Diagnosis
Copy chart
No responses yet for this question.
3. Urine protein/Creatinine ratio
Copy chart
No responses yet for this question.
4. BP at Diagnosis
Copy chart
No responses yet for this question.
5. Need for Dialysis
Copy chart
No responses yet for this question.
E. Laboratory Diagnosis
1. Hemoglobin
Copy chart
No responses yet for this question.
2. Platelet Count
Copy chart
No responses yet for this question.
3. LDH
Copy chart
No responses yet for this question.
4. Haptoglobin
Copy chart
No responses yet for this question.
5. Reticulocyte Count
Copy chart
No responses yet for this question.
6.  Schistocytes on Peripheral Smear
Copy chart
No responses yet for this question.
7. Direct Coombs test
Copy chart
No responses yet for this question.
8.  C3
Copy chart
No responses yet for this question.
9. C4
Copy chart
No responses yet for this question.
10. ADAMTS13 activity tested
Copy chart
No responses yet for this question.
IF YES: 
RESULT
Copy chart
No responses yet for this question.
11. STEC/Shiga toxin testing done
Copy chart
No responses yet for this question.
IF YES: 
RESULT
Copy chart
No responses yet for this question.
12. Other Infection Identified
Copy chart
No responses yet for this question.
13. Anti-factor H Antibody Tested
Copy chart
No responses yet for this question.
IF YES: 
RESULT
Copy chart
No responses yet for this question.
14. Complement Genetic Testing Done
Copy chart
No responses yet for this question.
IF YES: 
Copy chart
No responses yet for this question.
15. Variant classification
Copy chart
No responses yet for this question.
F. Biopsy and Rejection Assessment
1. Graft Biopsy Performed
Copy chart
No responses yet for this question.
2. Biopsy timing from TMA Suspicion
Copy chart
No responses yet for this question.
3. Biopsy findings:
Copy chart
No responses yet for this question.
4. C4d staining
Copy chart
No responses yet for this question.
5. Microvascular Inflammation
Copy chart
No responses yet for this question.
6. DSA at Diagnosis
Copy chart
No responses yet for this question.
7. ABMR Diagnosed
Copy chart
No responses yet for this question.
8. TCMR present
Copy chart
No responses yet for this question.
9. Electron Microscopy Done
Copy chart
No responses yet for this question.
10. Final biopsy impression
Copy chart
No responses yet for this question.
G. Suspected trigger
1. Most likely trigger
Copy chart
No responses yet for this question.
2. Was more than one trigger present? 
Copy chart
No responses yet for this question.
H. Treatment details
1. Initial Management
Copy chart
No responses yet for this question.
2.  Was Eculizumab Used? 
Copy chart
No responses yet for this question.
3. Indication for Eculizumab
Copy chart
No responses yet for this question.
4. Time from Diagnosis to First Eculizumab Dose
Copy chart
No responses yet for this question.
5. Eculizumab Dosing Schedule Used
Copy chart
No responses yet for this question.
6. Number of Doses
Copy chart
No responses yet for this question.
7. Duration of Therapy
Copy chart
No responses yet for this question.
8. Was Ravulizumab Used Later? 
Copy chart
No responses yet for this question.
9. Reason for stopping eculizumab
Copy chart
No responses yet for this question.
10. Vaccination before Eculizumab
Copy chart
No responses yet for this question.
11. Antibiotic prophylaxis given? 
Copy chart
No responses yet for this question.
12. Funding source
Copy chart
No responses yet for this question.
I. Outcomes
1. Hematological Response
Copy chart
No responses yet for this question.
2. Platelet Recovery Day
Copy chart
No responses yet for this question.
3.  LDH Normalization Day
Copy chart
No responses yet for this question.
4.  Creatinine at 1 Month
Copy chart
No responses yet for this question.
5.  Creatinine at 3 Months
Copy chart
No responses yet for this question.
6.  Creatinine at 6 Months
Copy chart
No responses yet for this question.
7.  Creatinine at 12 Months
Copy chart
No responses yet for this question.
8.  Dialysis Discontinued? 
Copy chart
No responses yet for this question.
9.  Graft Outcome
Copy chart
No responses yet for this question.
10.  TMA Recurrence after Treatment Withdrawal
Copy chart
No responses yet for this question.
11.  Infection after Eculizumab
Copy chart
No responses yet for this question.
If Yes
Kindly name the infection
Copy chart
No responses yet for this question.
12.  Other Adverse Events
Copy chart
No responses yet for this question.
13.  Mortality
Copy chart
No responses yet for this question.
J. Real-world Barriers and Opinion
1.  Main Barriers to Eculizumab Use
Copy chart
No responses yet for this question.

2. In which Cases would you Consider Eculizumab?

Copy chart
No responses yet for this question.
3. Do you support Creating a National Post-Transplant TMA Registry? 
Copy chart
No responses yet for this question.
4.  Are you Willing to Contribute Anonymized Cases? 
Copy chart
No responses yet for this question.
Settings
Responses
Manage how responses are collected and protected
Presentation
Manage how the form and responses are presented
Defaults
Form defaults
Settings applied to this form and new forms
Question defaults
Settings applied to all new questions
.